FDA Investigator: Ashar P. Parikh

- Ashar P. Parikh first started conducting FDA inspections in 2009, with the last inspection in 2024. Over that time, Ashar P. Parikh has conducted 164 inspections at 144 companies across 150 sites.

Documents

FDA 483 Dishman Carbogen Amcis Limited, Ahmedabad | 2024

Out-of-stock
Ashar P. Parikh
Human Drugs Form 483

FDA 483 IMI TAMI Institute for Research & Development Ltd, Kiryat Atta | 2022

Out-of-stock
Ashar P. Parikh
Human Drugs Form 483

FDA 483 Terumo Corporation, Nakakoma-Gun | 2018

Out-of-stock
Ashar P. Parikh
Human Drug Form 483

FDA 483 Pacific Biolabs, Inc, Hercules | 2018

Out-of-stock
Ashar P. Parikh
Human Drug Form 483

FDA 483 AndersonBrecon (UK) Limited, Hereford | 2018

Out-of-stock
Ashar P. Parikh
Human Drug Form 483

FDA 483 BioMarin Pharmaceutical Inc., Novato | 2017

Out-of-stock
Ashar P. Parikh
Human Drug Form 483

FDA 483 Novartis Pharmaceuticals Corporation, San Carlos | 2017

Out-of-stock
Ashar P. Parikh
Human Drug Form 483

FDA 483 Genentech, Inc., Oceanside | 2017

Out-of-stock
Ashar P. Parikh
Human Drug Form 483

FDA 483 Intarcia Therapeutics, Inc., Hayward | 2017

Out-of-stock
Ashar P. Parikh
Human Drug Form 483

FDA 483 Validation Systems Inc, Palo Alto | 2017

Out-of-stock
Ashar P. Parikh
Human Drug Form 483

FDA 483 Bushu Pharmaceuticals Ltd, Kodama-Gun | 2017

Out-of-stock
Ashar P. Parikh
Human Drug Form 483

FDA 483 Yakult Honsha Co., Ltd., Susono | 2017

Out-of-stock
Ashar P. Parikh
Human Drug Form 483

FDA 483 Hisamitsu Pharmaceutical Co., Inc., Utsunomiya | 2017

Out-of-stock
Ashar P. Parikh
Human Drug Form 483

FDA 483 Biomarin Pharmaceuticals Inc, Brisbane | 2016

Out-of-stock
Ashar P. Parikh
Human Drug Form 483

FDA 483 Kaiser Foundation Hospitals, Livermore | 2016

Out-of-stock
Ashar P. Parikh
Human Drug Form 483

FDA 483 All Points Manufacturing, Benicia | 2016

Out-of-stock
Ashar P. Parikh
Foods & Cosmetic Form 483

Co-Investigators (61)